On-demand Global IP Spotlight briefing on Latin America covering AI, SEPs, pharmaceuticals, patent prosecution and oppositions, with takeaways for U.S. stakeholders.
Brazil's 2025 SEP litigation experienced significant growth, with Rio courts becoming a key forum, marked by procedural innovations, FRAND emphasis, and emerging connected-car disputes.
Fulbright Medical’s Shanghai Stock Exchange IPO was terminated after extensive Johnson & Johnson patent litigation, including multiple infringement suits and rising damages claims.
Silimed secured a Munich PI against Polytech over EP2581193, halting polyurethane-coated implant manufacture and sales in Germany amid parallel UPC action.
São Paulo Court of Justice reinstated an injunction in a med-tech patent dispute, granting suspensive effect to J&J’s extraordinary appeals against Scitech.
BRPTO’s 2026 patent landscape maps satellite energy and space propulsion trends, showing Brazil’s growing filings and the dominance of research institutions.
The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.
Global settlement of pertuzumab biosimilar disputes across the U.S., UPC, the Netherlands and Brazil, highlighting Brazil’s key validity win and UPC order.
This BRPTO study analyzes 6,300 patent applications to map green innovation in Brazilian agriculture, highlighting biofertilizers and international cooperation.